Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
Aroda, Vanita R, González-Galvez, Guillermo, Grøn, Randi, Halladin, Natalie, Haluzík, Martin, Jermendy, György, Kok, Adri, Őrsy, Petra, Sabbah, Mohamed, Sesti, Giorgio, Silver, Robert
Published in The lancet. Diabetes & endocrinology (01.08.2019)
Published in The lancet. Diabetes & endocrinology (01.08.2019)
Get full text
Journal Article
G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension
Wirth, Angela, Benyó, Zoltán, Lukasova, Martina, Leutgeb, Barbara, Wettschureck, Nina, Gorbey, Stefan, Orsy, Petra, Horváth, Béla, Maser-Gluth, Christiane, Greiner, Erich, Lemmer, Björn, Schütz, Günther, Gutkind, J Silvio, Offermanns, Stefan
Published in Nature medicine (01.01.2008)
Published in Nature medicine (01.01.2008)
Get full text
Journal Article
Intracellular signaling pathways of muscarinic acetylcholine receptor-mediated detrusor muscle contractions
Balla, Helga, Borsodi, Kinga, Őrsy, Petra, Horváth, Béla, Molnár, Péter József, Lénárt, Ádám, Kosztelnik, Mónika, Ruisanchez, Éva, Wess, Jürgen, Offermanns, Stefan, Nyirády, Péter, Benyó, Zoltán
Published in American journal of physiology. Renal physiology (01.11.2023)
Published in American journal of physiology. Renal physiology (01.11.2023)
Get full text
Journal Article
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice
Sesti, Giorgio, Bardtrum, Lars, Dagdelen, Selcuk, Halladin, Natalie, Haluzík, Martin, Őrsy, Petra, Rodríguez, Martin, Aroda, Vanita R.
Published in Diabetes, obesity & metabolism (01.05.2020)
Published in Diabetes, obesity & metabolism (01.05.2020)
Get full text
Journal Article
IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy
Miller, Eden, Doshi, Ankur, Grøn, Randi, Jódar, Esteban, Őrsy, Petra, Ranthe, Mattis F., Sugimoto, Danny, Tentolouris, Nikolaos, Viljoen, Adie, Billings, Liana K.
Published in Diabetes, obesity & metabolism (01.12.2019)
Published in Diabetes, obesity & metabolism (01.12.2019)
Get full text
Journal Article
Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials
Janez, Andrej, Őrsy, Petra, Stachlewska, Karolina, Salvesen‐Sykes, Karen, Billings, Liana K., Philis‐Tsimikas, Athena
Published in Diabetes, obesity & metabolism (01.04.2020)
Published in Diabetes, obesity & metabolism (01.04.2020)
Get full text
Journal Article
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
Brown‐Frandsen, Kirstine, Emerson, Scott S., McGuire, Darren K., Pieber, Thomas R., Poulter, Neil R., Pratley, Richard E., Zinman, Bernard, Ranthe, Mattis F., Grøn, Randi, Lange, Martin, Moses, Alan C., Örsy, Petra, Buse, John B.
Published in Diabetes, obesity & metabolism (01.06.2019)
Published in Diabetes, obesity & metabolism (01.06.2019)
Get full text
Journal Article
Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice
Buday, Anna, Orsy, Petra, Godó, Mária, Mózes, Miklós, Kökény, Gábor, Lacza, Zsombor, Koller, Akos, Ungvári, Zoltán, Gross, Marie-Luise, Benyó, Zoltán, Hamar, Péter
Published in American journal of physiology. Heart and circulatory physiology (01.08.2010)
Published in American journal of physiology. Heart and circulatory physiology (01.08.2010)
Get full text
Journal Article
NK2 receptor-mediated detrusor muscle contraction involves G q/11 -dependent activation of voltage-dependent Ca 2+ channels and the RhoA-Rho kinase pathway
Dér, Bálint, Molnár, Péter József, Ruisanchez, Éva, Őrsy, Petra, Kerék, Margit, Faragó, Bernadett, Nyirády, Péter, Offermanns, Stefan, Benyó, Zoltán
Published in American journal of physiology. Renal physiology (01.11.2019)
Published in American journal of physiology. Renal physiology (01.11.2019)
Get full text
Journal Article
NK2 receptor-mediated detrusor muscle contraction involves Gq/11-dependent activation of voltage-dependent Ca2+ channels and the RhoA-Rho kinase pathway
Dér, Bálint, Molnár, Péter József, Ruisanchez, Éva, Őrsy, Petra, Kerék, Margit, Faragó, Bernadett, Nyirády, Péter, Offermanns, Stefan, Benyó, Zoltán
Published in American journal of physiology. Renal physiology (01.11.2019)
Published in American journal of physiology. Renal physiology (01.11.2019)
Get full text
Journal Article
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100units/mL at 26weeks: DUAL VIII, a randomized trial designed to resemble clinical practice
Sesti, Giorgio, Bardtrum, Lars, Dagdelen, Selcuk, Halladin, Natalie, Haluzík, Martin, Őrsy, Petra, Rodríguez, Martin, Aroda, Vanita R
Published in Diabetes, obesity & metabolism (01.05.2020)
Published in Diabetes, obesity & metabolism (01.05.2020)
Get full text
Journal Article
IDegLira Achieved Non-Inferior A1C Reduction, Weight Loss and Fewer Hypoglycemic Episodes While Using a Simple Regimen with Fewer Injections and Dose Adjustments Compared with Basal–Bolus Therapy
Miller, Eden, Jodar, Esteban, Khunti, Kamlesh, Sugimoto, Danny, Őrsy, Petra, Ranthe, Mattis F., Chan-Remillard, Sylvia, Viljoen, Adie
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
139 - IDegLira Achieved Non-Inferior A1C Reduction, Weight Loss and Fewer Hypoglycemic Episodes While Using a Simple Regimen with Fewer Injections and Dose Adjustments Compared with Basal–Bolus Therapy
Miller, Eden, Jodar, Esteban, Khunti, Kamlesh, Sugimoto, Danny, Őrsy, Petra, Ranthe, Mattis F., Chan-Remillard, Sylvia, Viljoen, Adie
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
18 - Rates of Major Adverse Cardiovascular Events and Mortality with Basal Insulin by Liraglutide Use: A DEVOTE Subanalysis
Brown-Frandsen, Kirstine, Emerson, Scott S., Marso, Steven P., McGuire, Darren K., Pieber, Thomas R., Poulter, Neil R., Zinman, Bernard, Grøn, Randi, Lange, Martin, Moses, Alan C., Őrsy, Petra, Ranthe, Mattis F., Pratley, Richard E., Woo, Vincent
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
Rates of Major Adverse Cardiovascular Events and Mortality with Basal Insulin by Liraglutide Use: A DEVOTE Subanalysis
Brown-Frandsen, Kirstine, Emerson, Scott S., Marso, Steven P., McGuire, Darren K., Pieber, Thomas R., Poulter, Neil R., Zinman, Bernard, Grøn, Randi, Lange, Martin, Moses, Alan C., Őrsy, Petra, Ranthe, Mattis F., Pratley, Richard E., Woo, Vincent
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
Signal transduction pathways of muscarinic receptors in the murine urinary bladder smooth muscle
Balla, Helga, Borsodi, Kinga, Örsy, Petra, Horváth, Béla, Molnár, Péter József, Ruisanchez, Éva, Nyirády, Péter, Wess, Jürgen, Offermanns, Stefan, Benyó, Zoltán
Published in Physiology (Bethesda, Md.) (01.05.2023)
Published in Physiology (Bethesda, Md.) (01.05.2023)
Get full text
Journal Article
Effects of IDegLira (Insulin Degludec/Liraglutide) in Patients with Poorly Controlled Type 2 Diabetes (T2D) with A1C >9%—Analyses from the DUAL Program
SUGIMOTO, DANNY, FRIAS, JUAN P., GOUET, DIDIER, TAKÁCS, RÓBERT, JIA, TING, ÖRSY, PETRA, BAIN, STEPHEN C.
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
147-OR: DUAL VIII: Significantly Longer Time to Treatment Intensification with Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) in a 104-Week (Wk) Randomized Trial Mirroring Clinical Practice
ARODA, VANITA R., GONZALEZ-GALVEZ, GUILLERMO, HALUZIK, MARTIN, SILVER, ROBERT J., GRØN, RANDI, HALLADIN, NATALIE, ÖRSY, PETRA, SESTI, GIORGIO
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
Abstract #239 Insulin Degludec/Liraglutide (Ideglira) Achieved Non-Inferior A1c Reduction; Weight Loss and Fewer Hypoglycemic Episodes while Using a Simple Regimen with Fewer Injections and Dose Adjustments Compared with Basal–Bolus Therapy: An Analysis of Dual VII
Miller, Eden, Jodar, Esteban, Khunti, Kamlesh, Sugimoto, Danny, Örsy, Petra, Ranthe, Mattis, Viljoen, Adie
Published in Endocrine practice (01.04.2018)
Published in Endocrine practice (01.04.2018)
Get full text
Journal Article